Pluribus Labs’s Procter & Gamble PG Stock Holding History

Pluribus Labs’s Portfolio PG Stock Details PG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,137	Closed	-$350K	–	178
2021 Q4	$350K	Buy	+2,137	New	+$317K	0.37%	106

Other funds holding PG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Pluribus Labs's PG Position: Q1 2022 in Review

Pluribus Labs sold out of Procter & Gamble (PG) in Q1 2022, closing a stake of 2,137 shares — an estimated $350K sold.

Pluribus Labs first reported a position in PG in Q4 2021 and held it in 1 quarter. The position peaked at $350K in Q4 2021. 3,289 funds tracked by Wall St. Rank hold PG as of Q1 2022.

Pluribus Labs reported no remaining Procter & Gamble position as of Q1 2022 after selling out during the quarter.
Pluribus Labs sold 2,137 Procter & Gamble shares in Q1 2022, an estimated $350K.
Pluribus Labs first reported a position in Procter & Gamble in Q4 2021 and held it in 1 quarter.
Pluribus Labs's Procter & Gamble position peaked at $350K in Q4 2021.
3,289 funds tracked by Wall St. Rank held Procter & Gamble as of Q1 2022.

Based on Pluribus Labs's 13F filing for Q1 2022, filed 16 May 2022.